The present invention relates a specific tetrahydroisoquinoline compound which is useful as a chemokine receptor type 3 (CCR3) antagonist, and a pharmaceutical composition comprising the same as an active ingredient. The tetrahydroisoquinoline compound of the present invention is useful for the treatment or prevention of a disease in which CCR3 participates.
本发明涉及一种可用作
趋化因子受体3型(CCR3)拮抗剂的特定
四氢异喹啉化合物,以及一种以其为活性成分的药物组合物。 本发明的
四氢异喹啉化合物可用于治疗或预防 CCR3 参与的疾病。